KAIST 생명과학 대학원 자기소개서 성공패턴과 입학시험 면접시험 기출문제 논술주제 면접자료 연구계획서 자소서입력사항 견본

소개

"KAIST 생명과학 대학원 자기소개서 성공패턴과 입학시험 면접시험 기출문제 논술주제 면접자료 연구계획서 자소서입력사항 견본"에 대한 내용입니다.

목차

<1부 제목 차례>
1. 소개의 글 ······················································································································ 2
2. 대학원 면접전 알아야 할 기본정보 ········································································· 7
가. KAIST의 기본정보 ······································································································ 7
나. KAIST의 연구활동 ······································································································ 8
다. KAIST 연구기관 ········································································································ 10
라. KAIST 국제 대학평가 ······························································································ 11
마. KAIST의 연구관련 국제교류 ················································································· 12
3. 시험을 보기전 주의해야할 기본 문제들 ······························································· 13
가. 제가 듣고 싶은 이야기는... ···················································································· 13
나. 최고경영자 생각의 중요성 ······················································································ 15
v 답변의 간결성과 꼬리질문 ······················································································· 19
가. 면접 문제에 대한 답변의 간결성 ········································································· 19
나. 꼬리질문의 유형 ········································································································ 20
다. 꼬리질문의 사례와 답변 ·························································································· 21
4. 전공관련 수학능력 기본을 점검하는 문제 ··························································· 23
5. 빈도 높은 논술주제 키워드 ····················································································· 73
7. 실전 심화학습 문제 ···································································································· 88
8. 인성검사 시사상식문제 ··························································································· 100
v 자소서 입력 항목 분석 ··························································································· 146
v 연구계획서 업무계획서 ··························································································· 150
가. 요 약 서(예시) ····································································································· 151
나. 업무추진 기본방향 ································································································ 153
다. 사업별 추진계획 ······································································································ 154
라. 추진전략 ···················································································································· 154
마. 추진일정 ···················································································································· 155
<표 차례>
[표 1] 의료기관의 경영철학이 중요한 이유 ······························································ 15
[표 2] 생명과학의 연구방법론 ···················································································· 23
[표 3] 재조합 DNA를 이용하여 생산된 의약품 ····················································· 30
[표 4] dna 복제모형의 비교 ······················································································· 56
[표 5] 공공기관 채용정책의 변화 ················································································ 70
[표 6] 면접 복장에 대하여 (여성) ··············································································· 88
[표 7] 인성검사문제와 시사상식문제 ······································································ 107
[표 8] 직무수행 목표 ·································································································· 154
[표 9] 세부과제 ············································································································ 154
[표 10] 추진일정 ············································································································ 156
<그림 차례>
그림 1 이런 칭찬 글도 있습니다. ············································································· 23
그림 2 유전자치료 방법 ································································································· 32
그림 3 바이오센서 시장규모 ························································································· 35
그림 4 dna칩 ···················································································································· 36
그림 5 단일클론항체의 형성과정 ················································································· 41
그림 6 세포융합항체의 이용 ························································································· 43
그림 7 단일클론 항체 생성과정 ··················································································· 46
그림 8 mRNA 유전 암호의 일부 ·············································································· 59
그림 9 디도수 공격 상황 ······························································································· 80
그림 10 사물인터넷 시장 규모와 성장세 ·································································· 82
그림 11 생산성이 높은 시스템 구축 방법론 사례 ·················································· 85
그림 12 ict를 기반으로 하는 농업간의 융합 ··························································· 87
그림 13 인성검사 주요 핵심 tip ··············································································· 102
그림 14 인성검사의 문항 구성 ·················································································· 104
그림 15 직무적성 고사 문제 사례( 시간 1분) ······················································· 124
그림 16 미세먼지의 크기 ···························································································· 131
그림 17 업무추진 기본방향 ······················································································ 153
그림 18 추천의 글 견본 1 ·························································································· 157
그림 19 추천의 글 견본 2 ·························································································· 157

본문내용

2. 대학원 면접전 알아야 할 기본정보
가. KAIST의 기본정보
Korea Advanced Institute of Science and Technology
과학 인재 양성과 국가 정책으로 추진하는 과학기술연구 수행을 위해 설립된 대한민국의 국립 특수대학원. 본원은 대전광역시 대덕연구개발특구 내 유성구에 있다. 영어 약칭은 KAIST이며, 2008년부터는 공식명칭이 'KAIST'로 통일되었다. 그러나 법인명은 여전히 한국과학기술원,. 보통의 국립대학교와 달리 대덕연구개발특구의 정부출연연구기관들과 마찬가지로 애초부터 별도의 법인으로 설립되었다. 예전엔 주로 ' 과기원'으로 부르기도 했다. 한국과학기술원법에 의하여 관리되고 있다. 타 대학들과 달리 정부내 감독부서는 교육부가 아니라 과학기술정보통신부이다. 이에 따라 타 대학교들이 적용받는 수시 6회 제한 등이 없다.

<중 략>

26) 생명과학에서의 분야는 의료 분야에서 어느 분야에 특히 활용성이 높으며 이러한 결과로 현재 타 산업부분에서 많이 활용되는 연구산물은 어떤 것들이라고 생각하나요?

27) 유전자 치료의 문제점은 무엇이 있나요?
유전자 치료는 바이러스를 운반체로 사용하기 때문에 삽입 부위, 발현시기, 발현 장소를 조절해야 하는 문제점이 남아 있다. 바이러스 운반체가 혈액 세포 증식과 관련된 유전자 부위에 삽입되면 비정상적으로 백혈구 수가 늘어나 백혈병이 진행되는 부작용이 생길 수 있다. 정상
ADA 유전자와 바이러스 DNA를 재조합할 때 DNA 재조합 기술이 사용되었다. 바이러스는 사람의 세포에 침입하여 자신의 DNA를 숙주 세포의 염색체에 끼워 넣어 증식하므로 정상 ADA 유전자의 운반체로 이용된다. 정상 ADA 유전자를 가진 세포를 조직 배양하여 대량으로 증식시킨 후 환자에게 주입하면 정상 ADA 유전자가 발현되어 ADA 단백질을 합성할 수 있다. 체세포를 이용한 유전자 치료는 체세포의 수명에 한계가 있으므로 주기적으로 정상 유전자를 가진 세포를 주입해야 하며, 생식 세포의 유전자까지 바뀐 것은 아니므로 유전병이 자손에게 유전된다.